Three Thousand Steps May Be Enough to Slow Alzheimer's
A Smaller Daily Goal With a Big Payoff
Tracking Nearly 300 Brains for Up to 14 Years
Movement Curbs Tau, Not Amyloid Plaques
The official takeaway is precise: physical activity did not reduce the toxic amyloid plaques targeted by current Alzheimer's drugs. What it did change was the buildup of misfolded tau protein in specific brain regions, the pathology tied to worsening memory and day-to-day function. In the most active participants, markers of dementia progression fell by almost half.
Three Years Gained at 3,000 Steps, Seven at 7,500
The dose curve has two clear steps. People averaging 3,000 to 5,000 steps a day saw cognitive decline delayed by about three years compared with sedentary peers. Those averaging 5,000 to 7,500 steps pushed that delay to around seven years. The strongest association sat in the 5,000 to 7,500 range, then plateaued: more walking did not necessarily add more protection.
A 78,000-Person British Study Points the Same Way
Why Sedentary Seniors Stand to Gain Most
The people with the most to gain are older adults who already show early brain changes but no symptoms, plus the families who care for them. A daily half-hour stroll is a goal a sedentary senior can actually keep, unlike an intimidating five-digit number. The usual caution applies: these are observational findings showing a link, not proof of cause, so steps are motivation rather than a prescription.
What Comes Next: Walk, but See a Doctor First
The authors stress there is no single activity standard suited to everyone. Anyone noticing memory loss, trouble following conversations, difficulty juggling tasks, or groping for words should talk to a doctor first, then build a walking plan that fits their body.
